• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底膜IV型胶原降解:不依赖金属蛋白酶的蛋白水解级联反应参与的证据。

Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

作者信息

Mackay A R, Corbitt R H, Hartzler J L, Thorgeirsson U P

机构信息

Division of Cancer Etiology, National Cancer Institute, NIH, Bethesda, Maryland 20892.

出版信息

Cancer Res. 1990 Sep 15;50(18):5997-6001.

PMID:2144209
Abstract

Current hypotheses suggest that both the plasmin system and metalloproteinases are involved in tumor invasion of basement membrane. In this study, we demonstrate that plasmin can directly degrade native and denatured type IV collagen in solution as well as in tissue sections. Tumor cell lines secreted plasminogen activators into culture supernatants that activated exogenous plasminogen to degrade type IV collagen in zymograms and to remove collagen IV immunoreactivity from tissue sections. Inhibition of metalloproteinase activity in culture supernatants by EDTA did not interfere with plasminogen-mediated type IV collagen degradation. We propose that tumor cells possess a mechanism for the degradation of basement membrane type IV collagen, independent of metalloproteinases but dependent on plasminogen conversion to plasmin.

摘要

目前的假说认为,纤溶酶系统和金属蛋白酶都参与肿瘤对基底膜的侵袭。在本研究中,我们证明纤溶酶能够直接降解溶液以及组织切片中的天然和变性IV型胶原。肿瘤细胞系将纤溶酶原激活剂分泌到培养上清液中,这些激活剂可激活外源性纤溶酶原,在酶谱中降解IV型胶原,并从组织切片中去除IV型胶原免疫反应性。用EDTA抑制培养上清液中的金属蛋白酶活性并不干扰纤溶酶原介导的IV型胶原降解。我们提出,肿瘤细胞拥有一种降解基底膜IV型胶原的机制,该机制不依赖于金属蛋白酶,而是依赖于纤溶酶原转化为纤溶酶。

相似文献

1
Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.基底膜IV型胶原降解:不依赖金属蛋白酶的蛋白水解级联反应参与的证据。
Cancer Res. 1990 Sep 15;50(18):5997-6001.
2
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.纤溶酶原激活剂(尿激酶)、纤溶酶和凝血酶对基底膜糖蛋白和胶原成分的影响。
Cancer Res. 1981 Nov;41(11 Pt 1):4629-36.
3
Directed migration of murine and human tumor cells to collagenases and other proteases.小鼠和人类肿瘤细胞向胶原酶及其他蛋白酶的定向迁移。
Cancer Res. 1989 Sep 1;49(17):4835-41.
4
Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.视黄酸对转移性大鼠乳腺腺癌细胞IV型胶原酶解及穿过重组基底膜侵袭的抑制作用。
Cancer Res. 1989 Apr 1;49(7):1698-706.
5
Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction.纤溶酶可诱导层粘连蛋白332(层粘连蛋白5)降解并使其功能失调,还会破坏真皮-表皮交界处基底膜的组装。
Br J Dermatol. 2008 Jul;159(1):49-60. doi: 10.1111/j.1365-2133.2008.08576.x. Epub 2008 Jul 1.
6
Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.维甲酸对人黑素瘤细胞通过重组基底膜的侵袭作用的抑制及其与蛋白水解酶和运动因子受体表达降低的关系。
Cancer Res. 1990 Jul 1;50(13):4121-30.
7
Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.尿激酶 - 纤溶酶系统成分对IV型胶原酶活性的调控:一种与细胞结合反应物相关的调节机制。
EMBO J. 1997 May 1;16(9):2319-32. doi: 10.1093/emboj/16.9.2319.
8
Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.不同转移潜能的大鼠乳腺腺癌细胞克隆对基底膜IV型胶原和肺内皮下基质的降解作用
Cancer Res. 1987 Sep 15;47(18):4869-76.
9
Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.口腔鳞状细胞癌细胞通过膜型I基质金属蛋白酶介导的I型胶原蛋白降解
Cancer Res. 2001 Aug 15;61(16):6264-75.
10
Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.纤溶酶原激活物-纤溶酶系统在角膜溃疡形成中作用的证据。
Invest Ophthalmol Vis Sci. 1980 Oct;19(10):1204-21.

引用本文的文献

1
Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.姜黄素类似物 L48H37 通过抑制 uPA 及其 JAK/STAT 信号通路抑制人骨肉瘤 U2OS 和 MG-63 细胞的迁移和侵袭。
Molecules. 2020 Dec 23;26(1):30. doi: 10.3390/molecules26010030.
2
Using antifibrinolytics to tackle neuroinflammation.使用抗纤溶药物治疗神经炎症。
Neural Regen Res. 2020 Dec;15(12):2203-2206. doi: 10.4103/1673-5374.284979.
3
Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf-MEK-ERK Pathway.
番茄碱通过抑制早老素 1 和 c-Raf-MEK-ERK 通路抑制人骨肉瘤 U2OS 和 HOS 细胞的侵袭和迁移。
Molecules. 2020 Jan 13;25(2):326. doi: 10.3390/molecules25020326.
4
Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade. Brassinin 通过抑制 PI3K/Akt/mTOR 信号级联来抑制肺癌细胞的侵袭潜能。
Molecules. 2019 Apr 22;24(8):1584. doi: 10.3390/molecules24081584.
5
Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice.抑制纤溶酶原激活物抑制剂1可减轻小鼠肝脂肪变性,但不能预防其进行性非酒精性脂肪性肝炎。
Hepatol Commun. 2018 Sep 26;2(12):1479-1492. doi: 10.1002/hep4.1259. eCollection 2018 Dec.
6
The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.新型 hsa-miR-12528 通过靶向 IGF-1R 抑制 AKT 级联的低磷酸化从而调控人肺癌的肿瘤发生和转移。
Cell Death Dis. 2018 May 1;9(5):493. doi: 10.1038/s41419-018-0535-8.
7
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.纤溶酶原缺乏症可延缓自身免疫性神经炎症性疾病的发病,并预防脱髓鞘和麻痹。
J Neurosci. 2017 Apr 5;37(14):3776-3788. doi: 10.1523/JNEUROSCI.2932-15.2017. Epub 2017 Mar 8.
8
A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia.组织型纤溶酶原激活剂治疗脑缺血对血脑屏障通透性机制的综述
Front Cell Neurosci. 2016 Jan 25;10:2. doi: 10.3389/fncel.2016.00002. eCollection 2016.
9
Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease.抑制溶酶体蛋白酶组织蛋白酶 D 可减少小鼠慢性肾脏病的肾纤维化。
Sci Rep. 2016 Feb 2;6:20101. doi: 10.1038/srep20101.
10
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?纤溶酶依赖性调节血脑屏障:tPA 诱导溶栓时的主要考虑因素?
J Cereb Blood Flow Metab. 2014 Aug;34(8):1283-96. doi: 10.1038/jcbfm.2014.99. Epub 2014 Jun 4.